Project Oncology
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:00:00
- Mais informações
Informações:
Sinopse
Guest: Vivek Subbiah, MD This episode will recap updates from the 2023 ASCO Annual Meeting regarding the abstract on comprehensive genomic profiling for non-small cell lung cancer (NSCLC). Join Dr. Vivek Subbiah, Chief of Early Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, to learn more.
